Dec. 13 at 5:43 PM
$OSTX In my opinion, our price fell victim to the broader market and swing traders that expected news on Friday. The reality is that the actual response from the FDA can take up to 30 days, though I wouldn’t expect it to take that long. The earliest we could expect to hear something is Monday. The company has overachieved at every data check point and there is no factual indication that should lead anyone to believe that they won’t come out of this meeting with positive news as well.
If endpoints are agreed upon the stock price will boom, because the likelihood of the FDA accepting a BLA submission skyrockets, which then skyrockets the likelihood that they receive a PRV. Remember, this is just one avenue the company is heading down!Big money investors know this domino effect and the retail investors, like us, who they can’t shake out, will be the few that get to make the big bucks alongside them. 🤙
